BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 31159629)

  • 1. Normative Data for the Montreal Cognitive Assessment in Greek Older Adults With Subjective Cognitive Decline, Mild Cognitive Impairment and Dementia.
    Poptsi E; Moraitou D; Eleftheriou M; Kounti-Zafeiropoulou F; Papasozomenou C; Agogiatou C; Bakoglidou E; Batsila G; Liapi D; Markou N; Nikolaidou E; Ouzouni F; Soumpourou A; Vasiloglou M; Tsolaki M
    J Geriatr Psychiatry Neurol; 2019 Sep; 32(5):265-274. PubMed ID: 31159629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the Discrimination of Subjective Cognitive Decline from Cognitively Healthy Adulthood and Mild Cognitive Impairment Possible? A Pilot Study Utilizing the R4Alz Battery.
    Poptsi E; Moraitou D; Tsardoulias E; Symeonidisd AL; Tsolaki M
    J Alzheimers Dis; 2020; 77(2):715-732. PubMed ID: 32741834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Normative Adjustments to the Montreal Cognitive Assessment.
    Pugh EA; Kemp EC; van Dyck CH; Mecca AP; Sharp ES;
    Am J Geriatr Psychiatry; 2018 Dec; 26(12):1258-1267. PubMed ID: 30314940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Montreal Cognitive Assessment and Discriminant Power of Montreal Cognitive Assessment Subtests in Patients With Mild Cognitive Impairment and Alzheimer Dementia in Turkish Population.
    Kaya Y; Aki OE; Can UA; Derle E; Kibaroğlu S; Barak A
    J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):103-9. PubMed ID: 24578463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the Cutoff of the MoCA too High? Longitudinal Data From Highly Educated Older Adults.
    Elkana O; Tal N; Oren N; Soffer S; Ash EL
    J Geriatr Psychiatry Neurol; 2020 May; 33(3):155-160. PubMed ID: 31500493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults.
    Trzepacz PT; Hochstetler H; Wang S; Walker B; Saykin AJ;
    BMC Geriatr; 2015 Sep; 15():107. PubMed ID: 26346644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Quick Mild Cognitive Impairment (Qmci) screen to the Montreal Cognitive Assessment (MoCA) in an Australian geriatrics clinic.
    Clarnette R; O'Caoimh R; Antony DN; Svendrovski A; Molloy DW
    Int J Geriatr Psychiatry; 2017 Jun; 32(6):643-649. PubMed ID: 27427212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MoCA Test: normative and diagnostic accuracy data for seniors with heterogeneous educational levels in Brazil.
    Cesar KG; Yassuda MS; Porto FHG; Brucki SMD; Nitrini R
    Arq Neuropsiquiatr; 2019 Nov; 77(11):775-781. PubMed ID: 31826133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normative Data for the Montreal Cognitive Assessment in a Lebanese Older Adult Population.
    Hayek M; Tarabey L; Abou-Mrad T; Fadel P; Abou-Mrad F
    J Clin Neurosci; 2020 Apr; 74():81-86. PubMed ID: 32007375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptation and Validation of the Memory Alteration Test (M@T) in Greek Middle-Aged, Older, and Older-Old Population with Subjective Cognitive Decline and Mild Cognitive Impairment.
    Lazarou I; Moraitou D; Papatheodorou M; Vavouras I; Lokantidou C; Agogiatou C; Gialaoutzis M; Nikolopoulos S; Stavropoulos TG; Kompatsiaris I; Tsolaki M
    J Alzheimers Dis; 2021; 84(3):1219-1232. PubMed ID: 34657882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The repeatable battery for the assessment of the neuropsychological status (RBANS): a diagnostic validity study in Greek elderly.
    Tsatali M; Fotiadou F; Giaglis G; Tsolaki M
    Aging Clin Exp Res; 2019 Sep; 31(9):1305-1312. PubMed ID: 30471005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study on the validations of three cognitive screening tests in identifying subtle cognitive decline.
    Pan FF; Huang L; Chen KL; Zhao QH; Guo QH
    BMC Neurol; 2020 Mar; 20(1):78. PubMed ID: 32138678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Montreal Cognitive Assessment (MoCA) in Spanish as a screening tool for mild cognitive impairment and mild dementia in patients over 65 years old in Bogotá, Colombia.
    Gil L; Ruiz de Sánchez C; Gil F; Romero SJ; Pretelt Burgos F
    Int J Geriatr Psychiatry; 2015 Jun; 30(6):655-62. PubMed ID: 25320026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short Montreal Cognitive Assessment.
    Larner AJ
    J Geriatr Psychiatry Neurol; 2017 Mar; 30(2):104-108. PubMed ID: 28013571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Czech Montreal Cognitive Assessment for Mild Cognitive Impairment due to Alzheimer Disease and Czech Norms in 1,552 Elderly Persons.
    Bartos A; Fayette D
    Dement Geriatr Cogn Disord; 2018; 46(5-6):335-345. PubMed ID: 30513529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis.
    Ciesielska N; Sokołowski R; Mazur E; Podhorecka M; Polak-Szabela A; Kędziora-Kornatowska K
    Psychiatr Pol; 2016 Oct; 50(5):1039-1052. PubMed ID: 27992895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Montreal Cognitive Assessment After Omission of Hearing-Dependent Subtests: Psychometrics and Clinical Recommendations.
    Al-Yawer F; Pichora-Fuller MK; Phillips NA
    J Am Geriatr Soc; 2019 Aug; 67(8):1689-1694. PubMed ID: 31018015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Montreal Cognitive Assessment and the Mini-Mental State Examination in detecting multi-domain mild cognitive impairment in a Chinese sub-sample drawn from a population-based study.
    Dong Y; Yean Lee W; Hilal S; Saini M; Wong TY; Chen CL; Venketasubramanian N; Ikram MK
    Int Psychogeriatr; 2013 Nov; 25(11):1831-8. PubMed ID: 23870281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.
    Kokubo N; Yokoi Y; Saitoh Y; Murata M; Maruo K; Takebayashi Y; Shinmei I; Yoshimoto S; Horikoshi M
    BMC Psychiatry; 2018 Jul; 18(1):220. PubMed ID: 29976167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.